Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CFO Greg Zante sold 56,295 shares of the stock in a transaction on Tuesday, April 11th. The stock was sold at an average price of $18.00, for a total transaction of $1,013,310.00. Following the completion of the sale, the chief financial officer now directly owns 149,279 shares of […]